1DiGiovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol,2001,45(5) :S176 - 182.
2Bickers DR, Saurat JH. Isotretinoin: A state-of-the-art conference. J Am Acad Dermatol, 2001 ,45(5) :S125-128.
3Kochhar DM, Christian MS. Tretinoin: a review of the nonclinical developmental toxicology experience. J Am Acad Dermatol, 1997, 36(3 Pt 2) :S47 -59.
4Nan H. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. J Am Acad Dermatol, 2001, 45(5) :S183 - 187.
6Sturkenboom MC, de Jong-Van Den Berg LT, van Voorst-Vader PC,et al. Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment. Br J Clin Pharmacol, 1994, 38(3) :229 -235.
7Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol,2001,45(4) :515 -519.
8Jacobs DG, Deutsch NL, Brewer M. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol, 2001, 45(5):S168 -175.
9Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol, 2002, 46(4):505-509.
10Hammer CJ 3rd, Carter CC, Hanifin JM. Peripheral neuropathy during etretinate therapy for psoriasis. J Am Acad Dermatol, 1993,28(2Pt 1 ) :272 -273.
9Shin J,Cheetham TC,Wong L,et al.The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system[J].Journal of the American Academy of Dermatology,2011,65(6):1 117.
10Kanerva LO,Johansson E,Niemi KM. Epidermodysplasia verruciformis.Clinical and light-and electron-microscopic observations during etretinate therapy[J].Arch Derrautol Res,1985,(02):153-160.
